Impact of HIV infection on cardiac deformation

Revista Portuguesa de Cardiologia

Volumn 33, Issue 9, 2014, Pages 501-509

  Mendes, Lígia ^a   Silva, Daniela ^b   Miranda, Carla ^a   Sá, Joana ^a   Duque, Luís ^a   Duarte, Nelson ^a   Brito, Paula ^a   Bernardino, Leonel ^a   Poças, José ^a  

^a HOSPITAL DE SÃO BERNARDO   (Portugal)

^b Hospital Militar de Belem   (Portugal)

Author keywords

Color tissue Doppler; HIV infection; Myocardial mechanics; Myocardium deformation; Speckle tracking

Indexed keywords

ADULT; ARTICLE; ASYMPTOMATIC INFECTION; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DISEASE DURATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE INJURY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MALE; MYOCARDIAL DEFORMATION; MYOCARDIAL DISEASE; TISSUE DOPPLER IMAGING; CASE CONTROL STUDY; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; HIV INFECTIONS; MIDDLE AGED; PATHOPHYSIOLOGY; VIROLOGY; VIRUS LOAD;

ADULT; ASYMPTOMATIC INFECTIONS; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VIRAL LOAD;

EID: 84908212221     PISSN: 08702551     EISSN: 21742030     Source Type: Journal    
DOI: 10.1016/j.repc.2013.12.006     Document Type: Article

References (35)

1. www.indexmundi.com/pt.
2. H. Valdez, T.K. Chowdhry, and R. Asaad Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995-1999 Clin Infect Dis 32 2001 1487 1493
3. F.J. Palella Jr., R.K. Baker, and A.C. Moorman Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV Outpatient Study J Acquir Immune Defic Syndr 43 2006 27 34
4. N.F. Crum, R.H. Riffenburgh, and S. Wegner Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras J Acquir Immune Defic Syndr 41 2006 194 200
5. D. Hooshyar, D.L. Hanson, and M. Wolfe Trends in perimortal conditions and mortality rates among HIV-infected patients AIDS 21 2007 2093 2100
6. A. Mocroft, P. Reiss, and J. Gasiorowski Serious fatal and non fatal non-AIDS defining illnesses in Europe J Acquir Immune Defic Syndr 55 2010 262 270
7. M. Saves, G. Chene, and P. Ducimetiere Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population Clin Infect Dis 37 2003 292 298
8. S.D. Holmberg, A.C. Moorman, and A.E. Greenberg Trends in rates of myocardial infarction among patients with HIV N Engl J Med 350 2004 730 732
9. S.E. Dolan, C. Hadigan, and K.M. Killilea Increased cardiovascular disease risk indices in HIV-infected women J Acquir Immune Defic Syndr 39 2005 44 54
10. DAD Study Group, N. Friis-Møller, P. Reiss, and A.C. Sabin Class of antiretroviral drugs and the risk of myocardial infarction N Engl J Med 356 2007 1723 1735
11. I. Sudano, L.E. Spieker, and G. Noll Cardiovascular disease in HIV infection Am Heart J 151 2006 1147 1155
12. G. Barbaro Cardiovascular manifestations of HIV infection Circulation 106 2002 1420 1425
13. G. Barbarinia, and G. Barbaro Incidence of the involvement of the cardiovascular system in HIV infection AIDS 17 Suppl. 1 2003 s46 s50
14. R. Bruno, P. Sacchi, and G. Filice Overview on the incidence and the characteristics of HIV-related opportunistic infections and neoplasms of the heart: impact of highly active antiretroviral therapy AIDS 17 Suppl. 1 2003 S83 S87
15. J.V. Baker, and J.D. Lundgren Cardiovascular implications from untreated human immunodeficiency virus infection Eur Heart J 32 2011 945 951
16. W. Lewis How does HIV/AIDS cause cardiomyopathy? Dialogues Cardiovasc Med 12 2007 27 36
17. G. Nayak, M. Ferguson, and D.R. Tribble Cardiac diastolic dysfunction is prevalent in HIV-infected patients AIDS Patient Care STDS 23 2009 231 238
18. T. Kuznetsova, L. Herbots, and B. López Prevalence of left ventricular diastolic dysfunction in a general population Circ Heart Fail 2 2009 105 112
19. N. Reinsch, K. Neuhaus, and S. Esser Prevalence of cardiac diastolic dysfunction in HIV-infected patients: results of the HIV-HEART Study HIV Clin Trials 11 2010 156 162
20. M.R. Zile, and D.L. Brutsaert New concepts in diastolic dysfunction and diastolic heart failure: Part I: Diagnosis, prognosis, and measurements of diastolic function Circulation 105 2002 1387 1393
21. R.M. Lang, M. Bierig, and R. Devereux Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
22. S.F. Nagueh, C.P. Appleton, and T.C. Gillebert Recommendations for the evaluation of left ventricular diastolic function by echocardiography J Am Soc Echocardiogr 22 2009 107 133
23. V. Mor-Avi, R.M. Lang, and L.P. Badano Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications J Am Soc Echocardiogr 24 2011 277 313
24. J.M. Bland-Altman Comparing methods of measurement: why plotting difference against standard method is misleading Lancet 346 1995 1085 1087
25. N. Lohse, A.E. Hansen, and G. Pedersen Survival of persons with and without HIV infection in Denmark, 1995-2005 Ann Intern Med 146 2007 87 95
26. C. Lewden, G. Chene, and P. Morlat HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population J Acquir Immune Defic Syndr 46 2007 72 77
27. P.Y. Hsue, P.W. Hunt, and J.E. Ho Impact of HIV infection on diastolic function and left ventricular mass Circ Heart Fail 3 2010 132 139
28. I. Schuster, G.J. Thöni, and S. Edérhy Subclinical cardiac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy Am J Cardiol 101 2008 1213 1217
29. L. Luo, Y. Ye, and Z. Liu Assessment of cardiac diastolic dysfunction in HIV-infected people without cardiovascular symptoms in China Int J STD AIDS 21 2010 814 818
30. K.E. Mondy, J. Gottdiener, E.T. Overton SUN Study Investigators High prevalence of echocardiographic abnormalities among HIV-infected persons in the era of highly active antiretroviral therapy Clin Infect Dis 52 2011 378 386
31. U. Oliviero, G. Bonadies, and G. Bosso Impaired diastolic function in naïve untreated human immunodeficiency virus infected patients World J Cardiol 2 2010 98 103
32. H. Geyer, G. Caracciolo, and H. Abe Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications J Am Soc Echocardiogr 23 2010 351 369
33. H. Lai, A. Redheuil, and W. Tong HIV infection and abnormal regional ventricular function Int J Card Imaging 25 2009 809 817
34. G. Pozzan, C. Pagliari, and F.F. Tuon Diffuse-regressive alterations and apoptosis of myocytes: possible causes of myocardial dysfunction in HIV-related cardiomyopathy Int J Cardiol 132 2009 90 95
35. J.J. Monsuez, L. Escaut, and E. Teicher Cytokines in HIV-associated cardiomyopathy Int J Cardiol 120 2007 150 157